L-Asparaginase-induced fulminating liver dysfunction

MeSH terms

• Adult
• Antineoplastic Agents / administration & dosage
• Antineoplastic Agents / adverse effects*
• Antineoplastic Agents / therapeutic use
• Antineoplastic Combined Chemotherapy Protocols / administration & dosage
• Antineoplastic Combined Chemotherapy Protocols / adverse effects
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Asparaginase / administration & dosage
• Asparaginase / adverse effects*
• Asparaginase / therapeutic use
• Chemical and Drug Induced Liver Injury / diagnostic imaging
• Chemical and Drug Induced Liver Injury / drug therapy
• Chemical and Drug Induced Liver Injury / physiopathology*
• Cholagogues and Choleretics / therapeutic use
• Drug Monitoring
• Female
• Humans
• Induction Chemotherapy / adverse effects
• Leukemia, B-Cell / drug therapy
• Liver / diagnostic imaging
• Liver / drug effects*
• Protective Agents / therapeutic use
• Radiography
• Severity of Illness Index
• Treatment Outcome
• Ursodeoxycholic Acid / therapeutic use